{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:58:54Z","timestamp":1793321934261,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary &amp; Pancreatic Diseases International"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.hbpd.2020.07.004","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T21:24:48Z","timestamp":1595539488000},"page":"515-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management"],"prefix":"10.1016","volume":"19","author":[{"given":"Dimitrios","family":"Schizas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Mastoraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Routsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Papapanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Tsapralis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Vassiliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Toutouzas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Felekouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2020.07.004_bib0001","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s00595-006-3276-8","article-title":"Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"36","author":"Lee","year":"2006","journal-title":"Surg Today"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0002","doi-asserted-by":"crossref","first-page":"12615","DOI":"10.3748\/wjg.v20.i35.12615","article-title":"Risk factors for combined hepatocellular-cholangiocarcinoma: a hospital-based case-control study","volume":"20","author":"Zhou","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0003","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.7150\/jca.23921","article-title":"Surgical treatment of combined hepatocellular-cholangiocarcinoma is as effective in elderly patients as it is in younger patients: a propensity score matching analysis","volume":"9","author":"Tao","year":"2018","journal-title":"J Cancer"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0004","doi-asserted-by":"crossref","DOI":"10.1177\/1073274817729245","article-title":"Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"24","author":"Massarweh","year":"2017","journal-title":"Cancer Control"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0005","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1586\/17474124.2015.1028363","article-title":"The evolving epidemiology of hepatocellular carcinoma: a global perspective","volume":"9","author":"Wallace","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0006","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0007","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s11605-018-3756-3","article-title":"The predictive value of staging systems and inflammation scores for patients with combined hepatocellular cholangiocarcinoma after surgical resection: a retrospective study","volume":"22","author":"He","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0008","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.3748\/wjg.v22.i18.4459","article-title":"Combined hepatocellular cholangiocarcinoma: controversies to be addressed","volume":"22","author":"Wang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0009","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12876-017-0584-y","article-title":"Influence of cirrhosis on long-term prognosis after surgery in patients with combined hepatocellular-cholangiocarcinoma","volume":"17","author":"Zhou","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0010","first-page":"403","article-title":"Primary carcinoma of the liver","volume":"126","author":"Wells","year":"1903","journal-title":"Am J Sci"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0011","first-page":"647","article-title":"Combined liver cell and bile duct carcinoma","volume":"25","author":"ALLEN","year":"1949","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0012","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/1097-0142(19850101)55:1<124::AID-CNCR2820550120>3.0.CO;2-Z","article-title":"Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study","volume":"55","author":"Goodman","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0013","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/JHC.S159808","article-title":"Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist","volume":"5","author":"Quaglia","year":"2018","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0014","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.crad.2016.11.003","article-title":"Imaging features predict prognosis of patients with combined hepatocellular-cholangiocarcinoma","volume":"72","author":"Mao","year":"2017","journal-title":"Clin Radiol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40880-016-0146-7","article-title":"Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study","volume":"35","author":"Zhao","year":"2016","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0016","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4254\/wjh.v9.i6.300","article-title":"Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma","volume":"9","author":"Gera","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0017","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/jgh.14547","article-title":"Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers","volume":"34","author":"Wakizaka","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0018","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/JHC.S159805","article-title":"Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions","volume":"6","author":"Stavraka","year":"2018","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0019","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.7150\/jca.23229","article-title":"A novel risk prediction model for patients with combined hepatocellular-cholangiocarcinoma","volume":"9","author":"Tian","year":"2018","journal-title":"J Cancer"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0020","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.6004\/jnccn.2018.7053","article-title":"Systemic therapy for combined hepatocellular-cholangiocarcinoma: a single-institution experience","volume":"16","author":"Trikalinos","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0021","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1111\/cas.13656","article-title":"Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma","volume":"109","author":"Kobayashi","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0022","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejro.2014.07.001","article-title":"Current update on combined hepatocellular-cholangiocarcinoma","volume":"1","author":"Maximin","year":"2014","journal-title":"Eur J Radiol Open"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0023","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jso.25331","article-title":"Management and outcomes among patients with mixed hepatocholangiocellular carcinoma: a population-based analysis","volume":"119","author":"Spolverato","year":"2019","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0024","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.amjsurg.2004.03.018","article-title":"Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma","volume":"189","author":"Koh","year":"2005","journal-title":"Am J Surg"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0025","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1245\/s10434-012-2328-0","article-title":"Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis","volume":"19","author":"Yin","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0026","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/00000478-200208000-00003","article-title":"Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study","volume":"26","author":"Tickoo","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0027","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/lt.23897","article-title":"Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor","volume":"20","author":"Garancini","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0028","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12957-019-1586-8","article-title":"Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends","volume":"17","author":"Wang","year":"2019","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0029","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4137\/CPath.S500","article-title":"Combined hepatocellular cholangiocarcinomas; analysis of a large database","volume":"1","author":"Wachtel","year":"2008","journal-title":"Clin Med Pathol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0030","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.14309\/ajg.0000000000000326","article-title":"Combined hepatocellular cholangiocarcinoma: a population-based retrospective study","volume":"114","author":"Ramai","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0031","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/liv.12563","article-title":"Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma","volume":"35","author":"Sasaki","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0032","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0033","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.bbadis.2018.01.027","article-title":"Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity","volume":"1864","author":"Liu","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0034","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/carcin\/bgs208","article-title":"Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGF\u03b2 signaling pathways","volume":"33","author":"Coulouarn","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0035","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jhep.2004.04.030","article-title":"Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas","volume":"41","author":"Cazals-Hatem","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0036","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/path.5243","article-title":"Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma","volume":"248","author":"Joseph","year":"2019","journal-title":"J Pathol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0037","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2017.01.010","article-title":"Mixed hepatocellular cholangiocarcinoma tumors: cholangiolocellular carcinoma is a distinct molecular entity","volume":"66","author":"Moeini","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0038","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s41379-019-0290-0","article-title":"Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma","volume":"32","author":"Balitzer","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0039","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3904\/kjim.2007.22.4.283","article-title":"A case of combined hepatocellular-cholangiocarcinoma with underlying schistosomiasis","volume":"22","author":"Hong","year":"2007","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0040","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jjco\/hyg056","article-title":"Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases","volume":"33","author":"Yano","year":"2003","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0041","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1148\/radiol.09091076","article-title":"Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization","volume":"255","author":"Kim","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0042","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/cncr.10392","article-title":"Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors","volume":"94","author":"Jarnagin","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0043","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1245\/s10434-008-9933-y","article-title":"Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience","volume":"15","author":"Portolani","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0044","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MCG.0b013e3181ce5dfa","article-title":"Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma","volume":"45","author":"Lee","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0045","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1742-1241.2007.01694.x","article-title":"Management of combined hepatocellular and cholangiocarcinoma","volume":"62","author":"Kassahun","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0046","first-page":"199","article-title":"Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review","volume":"5","author":"Chi","year":"2012","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0047","doi-asserted-by":"crossref","first-page":"287","DOI":"10.14701\/ahbps.2018.22.3.287","article-title":"Adrenal metastasis in sequentially developed combined hepatocellular carcinoma-cholangiocarcinoma: a case report","volume":"22","author":"Nugroho","year":"2018","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0048","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12328-018-0918-5","article-title":"Combined hepatocellular-cholangiocarcinoma successfully treated with sorafenib: case report and review of the literature","volume":"12","author":"Futsukaichi","year":"2019","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0049","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/j.1440-1746.2010.06430.x","article-title":"Pathology of combined hepatocellular-cholangiocarcinoma","volume":"25","author":"Yeh","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hep.29789","article-title":"cHCC-CCA: consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation","volume":"68","author":"Brunt","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0051","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1665-2681(19)30859-2","article-title":"Combined hepatocellular-cholangiocarcinoma (cHCC-CC): a distinct entity","volume":"13","author":"O'Connor","year":"2014","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0052","first-page":"649","article-title":"Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer","volume":"34","author":"Shirakawa","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0053","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jhep.2003.10.023","article-title":"Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype","volume":"40","author":"Kim","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0054","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/jclinpath-2015-203491","article-title":"The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type","volume":"69","author":"Akiba","year":"2016","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0055","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/hepr.13365","article-title":"Malic enzyme 1 is a potential marker of combined hepatocellular cholangiocarcinoma, subtype with stem-cell features, intermediate-cell type","volume":"49","author":"Mihara","year":"2019","journal-title":"Hepatol Res"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0056","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S1499-3872(14)60275-7","article-title":"Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery","volume":"13","author":"Lee","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0057","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12885-016-2156-x","article-title":"Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography","volume":"16","author":"Li","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0058","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.crad.2017.10.003","article-title":"Imaging features of combined hepatocellular-cholangiocarcinoma on contrast-enhanced ultrasound: correlation with clinicopathological findings","volume":"73","author":"Ye","year":"2018","journal-title":"Clin Radiol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0059","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/2050640618815378","article-title":"Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma","volume":"7","author":"Sagrini","year":"2019","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0060","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00261-013-0069-6","article-title":"Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma","volume":"39","author":"Shetty","year":"2014","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0061","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1111\/liv.14261","article-title":"Combining imaging and tumour biopsy improves the diagnosis of combined hepatocellular-cholangiocarcinoma","volume":"39","author":"Gigante","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0062","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jfma.2019.02.012","article-title":"Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection","volume":"119","author":"Chi","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0063","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1007\/s00261-019-01948-x","article-title":"Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018","volume":"44","author":"Ludwig","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0064","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1007\/s00330-018-5893-1","article-title":"How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI?","volume":"29","author":"Lee","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00261-017-1196-2","article-title":"LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma","volume":"43","author":"Fowler","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0066","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/01.sla.0000109154.00020.e0","article-title":"The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy","volume":"239","author":"Ercolani","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0067","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/jso.23289","article-title":"Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma","volume":"107","author":"Groeschl","year":"2013","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0068","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.hpb.2015.10.001","article-title":"Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database","volume":"18","author":"Vilchez","year":"2016","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0069","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/lt.25058","article-title":"Propensity-matched analysis of patients with mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing liver transplantation","volume":"24","author":"Lunsford","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198138","article-title":"The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection","volume":"13","author":"Na","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0071","doi-asserted-by":"crossref","first-page":"347","DOI":"10.21037\/jgo.2017.03.03","article-title":"Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy","volume":"8","author":"Rogers","year":"2017","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0072","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0073","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MOG.0000000000000626","article-title":"New systemic agents for hepatocellular carcinoma: an update 2020","volume":"36","author":"von Felden","year":"2020","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0074","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jhep.2019.09.025","article-title":"Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma","volume":"72","author":"Cheng","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0075","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13046-018-0777-4","article-title":"Immune checkpoint therapy in liver cancer","volume":"37","author":"Xu","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0076","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1742-1241.2007.01291.x","article-title":"Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography\/magnetic resonance imaging","volume":"62","author":"Lin","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0077","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12885-019-5398-6","article-title":"Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery","volume":"19","author":"He","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0078","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1245\/s10434-008-0278-3","article-title":"Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma","volume":"16","author":"Kim","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0079","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/MEG.0b013e3283625df9","article-title":"Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases","volume":"26","author":"Chu","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2020.07.004_bib0080","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1309\/AJCP66AVBANVNTQJ","article-title":"Clinicopathologic significance of combined hepatocellular-cholangiocarcinoma with stem cell subtype components with reference to the expression of putative stem cell markers","volume":"140","author":"Ikeda","year":"2013","journal-title":"Am J Clin Pathol"}],"container-title":["Hepatobiliary &amp; Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387220301387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387220301387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:41:52Z","timestamp":1761493312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387220301387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1499387220301387"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2020.07.004","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2020.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}